CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, L. C.
Right arrow Articles by Sampliner, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, L. C.
Right arrow Articles by Sampliner, R. E.

Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 1 41-46, Copyright © 1993 by American Association for Cancer Research


ARTICLES

Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps

LC Clark, LJ Hixson, GF Combs Jr, ME Reid, BW Turnbull and RE Sampliner
Department of Family and Community Medicine, University of Arizona College of Medicine, Tucson 85716.

The objective of this cross-sectional study was to determine whether plasma selenium concentration predicts the prevalence of adenomatous polyps of the colon and rectum. The source population for the study was 101 patients undergoing sequential colonoscopies at the Veterans Affairs Medical Center, Tucson, AZ. The study population was then limited to the 48 patients (all male) undergoing their initial colonoscopy who did not have a diagnosis of colorectal cancer. For each of these patients, a prediagnostic fasting plasma selenium concentration was determined. The data from this study suggest that fasting plasma selenium concentrations may be an important risk factor for colorectal adenomas. Patients with fasting plasma selenium concentrations below the median (< 128 mcg/liter) were significantly more likely to have one or more adenomatous polyps (prevalence odds ratio 4.2) and more adenomatous polyps (3.5 times) per patient. There was also a suggestion of a more proximal distribution of adenomatous polyps in the patients with a lower level of selenium. These associations were not confounded by age or smoking. The results of this study are consistent with the experimental animal studies, geographic mortality studies, and prospective cohort studies of selenium and colorectal cancer.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
U. Peters, N. Chatterjee, R. B. Hayes, R. E. Schoen, Y. Wang, S. J. Chanock, and C. B. Foster
Variation in the Selenoenzyme Genes and Risk of Advanced Distal Colorectal Adenoma
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1144 - 1154.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
U. Peters, N. Chatterjee, T. R. Church, C. Mayo, S. Sturup, C. B. Foster, A. Schatzkin, and R. B. Hayes
High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 315 - 320.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. A. NELSON, A.-C. GOULET, E. T. JACOBS, and P. LANCE
Studies into the Anticancer Effects of Selenomethionine against Human Colon Cancer
Ann. N.Y. Acad. Sci., November 1, 2005; 1059(1): 26 - 32.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. T. Hawk and B. Levin
Colorectal Cancer Prevention
J. Clin. Oncol., January 10, 2005; 23(2): 378 - 391.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. J. Duffield-Lillico, I. Shureiqi, and S. M. Lippman
Can Selenium Prevent Colorectal Cancer? A Signpost From Epidemiology
J Natl Cancer Inst, November 17, 2004; 96(22): 1645 - 1647.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. T. Jacobs, R. Jiang, D. S. Alberts, E. R. Greenberg, E. W. Gunter, M. R. Karagas, E. Lanza, L. Ratnasinghe, M. E. Reid, A. Schatzkin, et al.
Selenium and Colorectal Adenoma: Results of a Pooled Analysis
J Natl Cancer Inst, November 17, 2004; 96(22): 1669 - 1675.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Wallace, T. Byers, J. S. Morris, B. F. Cole, E. R. Greenberg, J. A. Baron, A. Gudino, V. Spate, and M. R. Karagas
Prediagnostic Serum Selenium Concentration and the Risk of Recurrent Colorectal Adenoma: A Nested Case-Control Study
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 464 - 467.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Chen, S. S. Mikhail, Y. W. Ding, G.-y. Yang, F. Bondoc, and C. S. Yang
Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats
Carcinogenesis, August 1, 2000; 21(8): 1531 - 1536.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Ip
Lessons from Basic Research in Selenium and Cancer Prevention
J. Nutr., November 1, 1998; 128(11): 1845 - 1854.
[Abstract] [Full Text]


Home page
GutHome page
M LANGMAN and P BOYLE
Chemoprevention of colorectal cancer
Gut, October 1, 1998; 43(4): 578 - 585.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1993 by the American Association for Cancer Research.